# OnCo record paper-nct03916627-lancet-gastroenterol-hepatol-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-nct03916627-lancet-gastroenterol-hepatol-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-nct03916627-lancet-gastroenterol-hepatol-2022" ;
  schema:name "Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial"@en ;
  schema:description "Published report from the trial registered as NCT03916627, in The lancet. Gastroenterology & hepatology (2022), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-nct03916627-lancet-gastroenterol-hepatol-2022/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2468-1253(21)00385-x>, <https://pubmed.ncbi.nlm.nih.gov/35065058/>, <https://europepmc.org/article/MED/35065058>, <https://clinicaltrials.gov/study/NCT03916627> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2468-1253(21)00385-x> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Marron TU, Fiel MI, Hamon P, et al." ;
  onco:trials <https://onco.cc/trials/nct03916627/> .